Abstract

RAMOS-LOPEZ, JF et al. Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%. Arch Soc Esp Oftalmol [online]. 2004, vol.79, n.8, pp.375-378. ISSN 0365-6691.

Purpose: To evaluate the efficacy of topical mitomycin C (MMC) 0.02% in treating conjunctival intraepithelial neoplasia (CIN). Methods: Three patients with CIN were treated with topical MMC 0.02%. Our follow-up period was twelve months (range 8-18 months). Results: CIN was resolved in all three cases without modifying the normal corneal and conjunctival architecture. Conclusions: Topical MMC 0.02% four times daily during two weeks is a useful alternative tool for the surgical management of CIN.

Keywords : Mitomycin C; conjunctival intraepithelial neoplasia.